MedAlliance has received CE mark certification for its Selution SLR 014 PTCA, a sirolimus drug-eluting balloon for treating patients with coronary arterial disease.

Sirolimus is an immunosuppressive drug frequently used to prevent organ rejection after a kidney transplant. The new certification is for treatment of lesions and in-stent restenosis.

The drug-eluting balloon uses “micro reservoirs” composed of biodegradable polymer that is mixed with the drug to control its release.